Page 51 - JCTR-11-2
P. 51

Journal of Clinical and
            Translational Research                                                       CMV secular trends and race




            Table 1. Baseline characteristics for the overall cohort and comparison between African‑American and non‑African‑American groups
            Baseline variable                       Non‑AA (n=974)           AA (n=1,287)             p‑value
            Age (mean±SD)                             53.3±13.8                51.6±12.8               0.002
            Female                                     37.6%                    43.4%                  0.005
            Weight (kg, mean±SD)                      87.2±19.9                88.9±18.1               0.039
            BMI (kg/m , mean±SD)                       29.6±8.6                30.2±5.5                0.071
                   2
            History of diabetes                        38.5%                    49.2%                 <0.001
            History of dialysis                        61.4%                    87.3%                 <0.001
            Years on dialysis                          2.0±2.4                  4.1±3.0               <0.001
            Years on the waiting list (mean±SD)        1.4±1.8                  1.6±1.9               <0.001
            Education high school or less              35.4%                    52.4%                 <0.001
            History pancreas transplant                 6.5%                     7.1%                  0.573
            Primary insurance                                                                         <0.001
             Private                                   34.8%                    16.2%
             Medicare                                  62.9%                    81.0%
             Medicaid                                   1.5%                     2.3%
             Other                                      0.9%                     0.6%
            Working at transplant                      33.6%                    22.3%                 <0.001
            Previous kidney transplant                 10.5%                     6.9%                  0.003
            Kidney pumped                              45.6%                    56.7%                 <0.001
            CMV D+/R−serostatus                        25.4%                    14.4%                 <0.001
            Median HLA mismatches (IQR)                4 (3, 5)                 5 (4, 5)              <0.001
            Median PRA (IQR)                          17 (0, 64)               37 (2, 83)             <0.001
            Cold ischemic time (hours, mean±SD)        14.2±9.1                16.3±7.7               <0.001
            Donor type                                                                                <0.001
             Living                                    24.1%                     4.7%
             Deceased brain death                      65.5%                    82.3%
             Deceased cardiac death                    10.4%                    13.0%
            Donor female                               43.3%                    35.8%                  0.003
            Donor hepatitis C+                          3.4%                     2.7%                  0.357
            Donor diabetes                              5.4%                     6.9%                  0.130
            Donor terminal creatinine (mean±SD)        1.3±1.0                  1.4±1.5                0.162
                        2
            Donor BMI (kg/m , mean±SD)                 27.2±6.1                27.6±6.4                0.104
            KDPI (%, mean±SD)                         39.3±25.2                39.9±24.9               0.643
            Delayed graft function                     17.2%                    28.3%                 <0.001
            Abbreviations: AA: African Americans; BMI: Body mass index; CMV: Cytomegalovirus; HLA: Human leukocyte antigen; IQR: Interquartile range;
            KDPI: Kidney donor profile index; PRA: Panel reactive antibody; SD: Standard deviation.

            literature. Isaacs  et al.  conducted a large prospective   received kidney transplants from living or deceased donors
                               23
            analysis utilizing the United Network for Organ Sharing   between 1990 and 2012.  Over the study period, 5-year
                                                                                   17
            renal transplant registry, involving 14,617  patients who   graft loss after living donation decreased from 37.4%
            received living-related donor kidney transplants in the   to 22.2% for AAs and from 20.8% to 13.9% for whites,
            US between 1988 and 1996.  Their findings revealed that,   whereas 5-year graft loss following deceased donation
                                  23
            after adjusting for potential confounding variables, AAs   decreased from 51.4% to 30.6% for AAs and 37.3% –
            were 1.7 times more likely than whites to experience graft   25.0% for whites. These findings revealed that the 5-year
                                                  17
            failure during the research period. Purnell et al.  analyzed   graft loss difference between AAs and whites narrowed
            all-cause graft loss in 63,910 AAs and 145,482 whites who   from  16.6%  to  8.3%  after  living  donation  and  14.1%  to

            Volume 11 Issue 2 (2025)                        45                            doi: 10.36922/jctr.24.00067
   46   47   48   49   50   51   52   53   54   55   56